Abstract:A series of novel substituted 2-pyrimidylbenzothiazoles incorporating either sulfonamide moieties or the amino group at C2 of the pyrimidine ring were synthesized and evaluated for its antiviral potency. The novel synthesis of the ring system was carried out by reacting guanidine or N-arylsulfonated guanidine with different derivatives of ylidene benzothiazole based on Michael addition pathways. The antiviral activity of the newly synthesized compounds was examined by a plaque reduction assay against HSV-1, CBV4, HAV HM 175, HCVcc genotype 4 viruses, and HAdV7. In the case of HSV-1, it was determined that 5 out of the 21 synthesized compounds exhibited superior viral reduction in the range of 70–90% with significant IC50, CC50, and SI values as compared with acyclovir. In the case of CBV4, nine compounds have shown more than 50% reduction. Comparable results were obtained for seven of these synthesized compounds when evaluated against HAV with only a couple of them showing 50% reduction or more against HCVcc genotype 4. Remarkably, one compound, 9a, has shown broad action against all five examined viruses, rendering it as potentially an effective antiviral agent. The five potent compounds 9a, 9b, 14b, 14g, and 14h against HSV-1 have also presented inhibitory activity against the Hsp90α protein with IC50 in the range of 4.87–10.47 μg/mL. Interestingly, a combination of the potent synthesized compounds with acyclovir led to IC50 values lower than that of acyclovir alone. The potent compounds 9a, 9b, 14b, 14g, and 14h were also docked inside the active site of Hsp90α to assess the interaction pattern between the tested compounds and the active site of the protein.

Synthesis and Antiviral Evaluation of Novel N-6 Substituted Adenosine Analogues

Synthesis of Janus Type Nucleoside Analogues and Their Preliminary Bioactivity

Synthesis and Biological Evaluation of Novel Benzimidazole Derivatives Bearing A Heterocyclic Ring at 4/5 Position

Synthesis and Antiviral Activity of a Series of Novel Quinoline Derivatives As Anti-Rsv or Anti-Iav Agents

Discovery of Novel Substituted N-(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide Analogues As Potent Human Adenovirus Inhibitors.

Antiviral Activities of Janus-type Nucleosides and Their Related Oxime-Intermediates

Design, Synthesis, and Antiviral Properties of 2-Aryl-1h-benzimidazole-4-carboxamide Derivatives

Synthesis and Antiviral Activity Against Coxsackie Virus B3 of Some Novel Benzimidazole Derivatives.

Doubly Homologated Dihalovinyl and Acetylene Analogues of Adenosine: Synthesis, Interaction with S-adenosyl-L-homocysteine Hydrolase, and Antiviral and Cytostatic Effects.

Synthesis of Novel Benzimidazole Derivatives and Their Antivirus Activity against Coxsackie Virus B3

Synthesis and Anti-HBV Activity of Novel Dihydropyrimidine Analogs

Synthesis and Antiviral Activities of Isonucleosides and Their Monophosphates

Efficient Synthesis and Docking Studies of Novel Benzothiazole-Based Pyrimidinesulfonamide Scaffolds as New Antiviral Agents and Hsp90α Inhibitors

Design, Synthesis and Biological Activity of Some Novel Benzimidazole Derivatives Against Coxsackie Virus B3

Synthesis and Antiviral Activity of 4H-[1,2,5]Oxadiazolo[3,4-d]pyrimidine-5,7-dione 1-Oxide Nucleosides

Synthesis and Bioactivity of Novel Trisubstituted Triazole Nucleosides.

Synthesis of New Pyrimidine Nucleoside Derivatives with Nitric Oxide Donors for Antiviral Activity

Synthesis, Characterization, and Biological Evaluation of Some Novel Quinoxaline Derivatives as Antiviral Agents

Synthesis and Quantitative Structure–activity Relationship (QSAR) Analysis of Some Novel Oxadiazolo[3,4-D]pyrimidine Nucleosides Derivatives As Antiviral Agents

Synthesis and antiviral activity against tobacco mosaic virus and 3D-QSAR of α-substituted-1,2,3-thiadiazoleacetamides

Synthesis and antiviral bioactivities of novel chiral bis-thiourea-type derivatives containing α-aminophosphonate moiety